科研成果详情

题名PRAME Promotes Cervical Cancer Proliferation and Migration via Wnt/β-Catenin Pathway Regulation
作者
发表日期2023-03
发表期刊Cancers   影响因子和分区
语种英语
原始文献类型Journal Article
关键词PRAME Wnt/β-catenin signaling cervical cancer proliferation tumorigenesis
其他关键词PREFERENTIALLY EXPRESSED ANTIGEN ; GENE-EXPRESSION ; MESENCHYMAL TRANSITION ; SIGNALING PATHWAY ; BETA-CATENIN ; MELANOMA ; METASTASIS ; BIOMARKERS ; PROGRESSION ; PROGNOSIS
摘要A significant burden is placed on the lives of females due to cervical cancer, which is currently the leading cause of cancer death among women. Preferentially expressed antigen in melanoma (PRAME) belongs to the CTA gene family and was found to be abnormally expressed among different types of cancers. Our previous research also indicated that PRAME was highly expressed in cervical cancer compared with normal tissues. However, the roles and detailed mechanisms of PRAME have not been explored in cervical cancer. In the present study, the expression of PRAME in cervical tissues and cells was detected by immunohistochemistry (IHC), qRT-PCR, and Western blotting. Additionally, CCK-8, BrdU, scratch, transwell, and flow cytometry assays were conducted to explore the function of PRAME in regulating the malignant biological behaviors of cervical cancer cells. Nude mice were used to confirm the role of PRAME in tumor growth in vivo. Furthermore, the Wnt inhibitor MSAB was used to verify the role of PRAME in regulating the Wnt/β-catenin pathway both in vitro and in vivo. The results of IHC, qRT-PCR, and Western blotting showed that PRAME was highly expressed in cervical cancer tissues and cells. PRAME knockdown attenuated cell growth, migration, and invasion; induced G0/G1 arrest; and increased cell apoptosis in C33A and SiHa cells through Wnt/β-catenin signaling regulation. However, the upregulation of PRAME exhibited the opposite effects accordingly, which could be partly reversed via MSAB treatment. The growth rate of xenograft tumors was enhanced when PRAME was overexpressed via Wnt/β-catenin signaling activation. Taken together, PRAME is associated with cervical cancer occurrence and progression mediated by Wnt/β-catenin signaling, suggesting that PRAME might be a factor in manipulating cervical carcinogenesis and a potential therapeutic target.
资助项目Natural Science Foundation of Zhejiang Province [LY21H160060]
出版者MDPI
ISSN2072-6694
EISSN2072-6694
卷号15期号:6
DOI10.3390/cancers15061801
页数17
WOS类目Oncology
WOS研究方向Oncology
WOS记录号WOS:000958351000001
收录类别PUBMED ; SCIE ; SCOPUS
URL查看原文
PubMed ID36980687
SCOPUSEID2-s2.0-85151338141
通讯作者地址[Zhu, Xueqiong]Department of Obstetrics and Gynecology,The Second Affiliated Hospital of Wenzhou Medical University,Wenzhou,325027,China
Scopus学科分类Oncology;Cancer Research
引用统计
文献类型期刊论文
条目标识符https://kms.wmu.edu.cn/handle/3ETUA0LF/174174
专题第二临床医学院、附属第二医院、育英儿童医院
附属第二医院
第一临床医学院(信息与工程学院)、附属第一医院_妇产科学
通讯作者Zhu, Xueqiong
作者单位
1.Department of Obstetrics and Gynecology,The Second Affiliated Hospital of Wenzhou Medical University,Wenzhou,325027,China;
2.Department of Obstetrics and Gynecology,Taizhou Women and Children’s Hospital of Wenzhou Medical University,Taizhou,318000,China
第一作者单位第二临床医学院,附属第二医院、育英儿童医院;  附属第二医院;  妇产科
通讯作者单位第二临床医学院,附属第二医院、育英儿童医院;  附属第二医院;  妇产科
第一作者的第一单位第二临床医学院,附属第二医院、育英儿童医院
推荐引用方式
GB/T 7714
Chen, Xin,Jiang, Mengying,Zhou, Shengjie,et al. PRAME Promotes Cervical Cancer Proliferation and Migration via Wnt/β-Catenin Pathway Regulation[J]. Cancers,2023,15(6).
APA Chen, Xin., Jiang, Mengying., Zhou, Shengjie., Chen, Hong., Song, Gendi., ... & Zhu, Xueqiong. (2023). PRAME Promotes Cervical Cancer Proliferation and Migration via Wnt/β-Catenin Pathway Regulation. Cancers, 15(6).
MLA Chen, Xin,et al."PRAME Promotes Cervical Cancer Proliferation and Migration via Wnt/β-Catenin Pathway Regulation".Cancers 15.6(2023).

条目包含的文件

条目无相关文件。
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Chen, Xin]的文章
[Jiang, Mengying]的文章
[Zhou, Shengjie]的文章
百度学术
百度学术中相似的文章
[Chen, Xin]的文章
[Jiang, Mengying]的文章
[Zhou, Shengjie]的文章
必应学术
必应学术中相似的文章
[Chen, Xin]的文章
[Jiang, Mengying]的文章
[Zhou, Shengjie]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。